Published in Cell Prolif on December 01, 2008
ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors. J Natl Cancer Inst (2011) 1.15
Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res (2010) 1.13
ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling. Mol Cell Biol (2011) 1.11
Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res (2014) 1.10
α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum. Adv Exp Med Biol (2012) 0.94
β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition. Cancer Res (2015) 0.88
Will chronic e-cigarette use cause lung disease? Am J Physiol Lung Cell Mol Physiol (2015) 0.87
Lung carcinoma signaling pathways activated by smoking. Chin J Cancer (2011) 0.87
Inhibition of the nicotinic acetylcholine receptors by cobra venom α-neurotoxins: is there a perspective in lung cancer treatment? PLoS One (2011) 0.85
Development of ferret as a human lung cancer model by injecting 4-(Nmethyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Lung Cancer (2013) 0.84
Nicotine stimulated dendritic cells could achieve anti-tumor effects in mouse lung and liver cancer. J Clin Immunol (2010) 0.84
From smoking to cancers: novel targets to neuronal nicotinic acetylcholine receptors. J Oncol (2011) 0.82
Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC). Cancer Biol Ther (2015) 0.81
Virtual screening against acetylcholine binding protein. J Biomol Screen (2011) 0.81
Novel link between prostaglandin E2 (PGE2) and cholinergic signaling in lung cancer: The role of c-Jun in PGE2-induced α7 nicotinic acetylcholine receptor expression and tumor cell proliferation. Thorac Cancer (2015) 0.80
Possible role of the α7 nicotinic receptors in mediating nicotine's effect on developing lung - implications in unexplained human perinatal death. BMC Pulm Med (2014) 0.80
A novel muscarinic antagonist R2HBJJ inhibits non-small cell lung cancer cell growth and arrests the cell cycle in G0/G1. PLoS One (2012) 0.80
Role of α7 nicotinic receptor in the immune system and intracellular signaling pathways. Cent Eur J Immunol (2015) 0.78
Agonist and antagonist effects of tobacco-related nitrosamines on human α4β2 nicotinic acetylcholine receptors. Front Pharmacol (2015) 0.76
Nicotinic acetylcholine receptors and cancer. Biomed Rep (2016) 0.75
Biomarkers of tobacco smoke exposure in racial/ethnic groups at high risk for lung cancer. Am J Public Health (2015) 0.75
β-Cryptoxanthin Reduced Lung Tumor Multiplicity and Inhibited Lung Cancer Cell Motility by Downregulating Nicotinic Acetylcholine Receptor α7 Signaling. Cancer Prev Res (Phila) (2016) 0.75
Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC). Oncotarget (2015) 0.75
Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se. Crit Rev Toxicol (2016) 0.75
Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers. Oncotarget (2017) 0.75
A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20
Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (1998) 10.89
Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol (2000) 3.26
A postoperative prognostic nomogram for renal cell carcinoma. J Urol (2001) 3.01
Systemic therapy for renal cell carcinoma. J Urol (2000) 2.89
Resection of metastatic renal cell carcinoma. J Clin Oncol (1998) 2.75
Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet (1999) 2.26
The medical problems of mass participation in athletic competition. The "City-to-Surf" race. Med J Aust (1972) 2.21
Outcome of the prenatally diagnosed congenital cystic adenomatoid lung malformation: a Canadian experience. Fetal Diagn Ther (2001) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol (1997) 2.10
Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. Am J Hum Genet (1995) 2.07
Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet (1996) 2.06
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
Cystectomy for bladder cancer: a contemporary series. J Urol (2001) 1.85
Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer (1999) 1.85
Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol (2001) 1.85
Multiple primary malignancies in renal cell carcinoma. J Urol (1998) 1.83
The type of urinary diversion after radical cystectomy significantly impacts on the patient's quality of life. Ann Surg Oncol (2000) 1.61
Unilateral laterothoracic exanthem. A clinicopathologic study of forty-eight patients. J Am Acad Dermatol (1996) 1.60
TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer (1998) 1.58
Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet (1998) 1.55
Successful treatment of Kasabach-Merritt syndrome with prednisone and epsilon-aminocaproic acid. Pediatr Hematol Oncol (1992) 1.54
The phenotype of partial dup(7q) reconsidered: a report of five new cases. Clin Genet (1988) 1.54
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging. Ann Oncol (2004) 1.51
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler (2007) 1.49
Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat Res (2008) 1.49
Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. J Clin Oncol (1990) 1.48
Clonal analysis of stably transduced human epidermal stem cells in culture. Proc Natl Acad Sci U S A (1996) 1.44
Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. J Clin Oncol (2000) 1.44
Evaluation of antilisterial action of cilantro oil on vacuum packed ham. Int J Food Microbiol (2002) 1.44
The effect of a social support boosting intervention on stress, coping, and social support in caregivers of children with HIV/AIDS. Nurs Res (1998) 1.43
Renal cell carcinoma. Curr Probl Cancer (1997) 1.43
Maedi-visna virus infection in sheep: a review. Vet Res (1998) 1.42
A comparative economic analysis of simvastatin versus atorvastatin: results of the Surrogate Marker Cost-Efficacy (SMaC) study. Clin Ther (1999) 1.40
Biogenic amines in fermented foods. Eur J Clin Nutr (2010) 1.40
The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc Natl Acad Sci U S A (1997) 1.39
Focal segmental glomerulosclerosis (FSG) 20 years later. From toddler to grown up. Clin Nephrol (1993) 1.39
The role of cardiopulmonary bypass and surfactant in pulmonary decompensation after surgery for congenital heart disease. J Thorac Cardiovasc Surg (1999) 1.38
Fetus in fetu or not? J Pediatr Surg (1989) 1.38
Second primary malignancies associated with renal cell carcinoma: influence of histologic type. Urology (2000) 1.38
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer (1991) 1.36
Localization of an ataxia-telangiectasia locus to a 3-cM interval on chromosome 11q23: linkage analysis of 111 families by an international consortium. Am J Hum Genet (1991) 1.34
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res (1997) 1.31
Successful treatment of autoimmune enteropathy with cyclosporine. J Pediatr (1990) 1.31
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. Ann Oncol (2007) 1.28
Nitric oxide, a biological effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. Eur Biophys J (1991) 1.27
Highly lytic and persistent lentiviruses naturally present in sheep with progressive pneumonia are genetically distinct. J Virol (1984) 1.26
Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. Cancer Res (1994) 1.24
DNA damage induced by auramine O in liver, kidney, and bone marrow of rats and mice, and in a human cell line (alkaline elution assay and SCE induction). J Toxicol Environ Health (1982) 1.24
Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum Pathol (1995) 1.24
The role of nuclear cap binding protein Cbc1p of yeast in mRNA termination and degradation. Mol Cell Biol (2000) 1.24
Mediastinoscopy as a standardised procedure for mediastinal lymph-node staging in non-small cell carcinoma. Do we have to accept the compromise? Eur J Cardiothorac Surg (2001) 1.22
Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol Genet Metab (2000) 1.21
Aberrant cervical thymus in children: three case reports and review of the literature. J Pediatr Surg (1990) 1.17
Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am J Hum Genet (1998) 1.16
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. Br J Cancer (2002) 1.16
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study. Neurology (2006) 1.15
Goats may experience reproductive failures and shed Coxiella burnetii at two successive parturitions after a Q fever infection. Res Vet Sci (2006) 1.14
Prevalence and determinants of misreporting among European children in proxy-reported 24 h dietary recalls. Br J Nutr (2012) 1.14
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays. J Proteome Res (2010) 1.13
Precocious thymic involution manifest by epithelial injury in the acquired immune deficiency syndrome. Hum Pathol (1984) 1.13
The novel human gene aprataxin is directly involved in DNA single-strand-break repair. Cell Mol Life Sci (2005) 1.12
Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis. Exp Cell Res (1998) 1.11
Redundant 3' end-forming signals for the yeast CYC1 mRNA. Proc Natl Acad Sci U S A (1995) 1.11
Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells. Cancer Res (1997) 1.11
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain (2006) 1.11
Influence of sample collection and preanalytical sample processing on the analyses of biological markers in the European multicentre study IDEFICS. Int J Obes (Lond) (2011) 1.10
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology (2005) 1.10
Antioxidant effect of red wine polyphenols on red blood cells. J Nutr Biochem (2000) 1.09
Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J Urol (1996) 1.08
Improvement of disseminated lymphangiomatosis with recombinant interferon therapy. Pediatr Pulmonol (2000) 1.08
hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay. Hum Mol Genet (2001) 1.08
p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol (1998) 1.08
Technological properties of Oenococcus oeni strains isolated from typical southern Italian wines. Lett Appl Microbiol (2010) 1.08
Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology (1996) 1.07
Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology (1996) 1.06
Thymoma in patients with MG: characteristics and long-term outcome. Neurology (2002) 1.06
Caregiver quality of life in multiple sclerosis: a multicentre Italian study. Mult Scler (2007) 1.06
Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor. Oncogene (1998) 1.06
Fatal pulmonary microsporidiosis due to encephalitozoon cuniculi following allogeneic bone marrow transplantation for acute myelogenous leukemia. Ultrastruct Pathol (2005) 1.05
Bilateral non-familial renal cell carcinoma. Ann Surg Oncol (1998) 1.05
Sudden unexpected deaths in infancy: what are the causes? J Pediatr (1999) 1.04
Precursor polypeptides to structural proteins of visna virus. J Virol (1982) 1.04
Variability among the sites by which curaremimetic toxins bind to torpedo acetylcholine receptor, as revealed by identification of the functional residues of alpha-cobratoxin. J Biol Chem (1999) 1.04
Cytogenetic biomonitoring of an Italian population exposed to pesticides: chromosome aberration and sister-chromatid exchange analysis in peripheral blood lymphocytes. Mutat Res (1991) 1.04
TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood (1995) 1.03
Border disease of sheep and goats. Vet Res (1998) 1.03
Studies on DNA binding of caffeine and derivatives: evidence of intercalation by DNA-unwinding experiments. Biochim Biophys Acta (1989) 1.01
Isolated congenital esophageal stenosis. J Pediatr Surg (1995) 1.01
Molecular determinants by which a long chain toxin from snake venom interacts with the neuronal alpha 7-nicotinic acetylcholine receptor. J Biol Chem (2000) 1.00
Wilms tumor and multicystic dysplastic kidney disease. J Urol (1997) 1.00
Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia. Cancer Res (1998) 0.99
Malignant mesenchymoma. Cancer (1996) 0.99